Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis
Clinical trial NCT03538951 · COMPLETED
Trial details
- NCT number
- NCT03538951
- Sponsor
- Vidac Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2018-12-10
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.